Genfit S.A. (GNFTY)

OTCMKTS · Delayed Price · Currency is USD

8.95

+0.78 (9.53%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Research and Development of Innovative Medicines and Diagnostic Solutions	70.69M	34.48M	26.25M	85.36M	8.68M
Research and Development of Innovative Medicines and Diagnostic Solutions Growth	105.01%	31.38%	-69.25%	883.14%	-77.72%
Total	70.69M	34.48M	26.25M	85.36M	8.68M
Total Growth	105.01%	31.38%	-69.25%	883.14%	-77.72%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
France	67.00M	28.57M	20.20M	80.07M	765.00K
France Growth	134.56%	41.45%	-74.78%	10366.54%	-
Total	67.00M	28.57M	20.20M	80.07M	765.00K
Total Growth	134.56%	41.45%	-74.78%	10366.54%	-

Source: S&P Global Market Intelligence.